En español

Menu

Publications

Quick Links

COVID-19 is an emerging, rapidly evolving situation.


Get the latest information from CDC (Coronavirus.gov) | NIH Resources | NIDA Resources

Meetings & Events

Public Meeting on Patient-Focused Drug Development for Stimulant Use Disorder

Details

March 10, 2020 - 12:30pm to 5:00pm
Silver Spring Civic Building, 1 Veterans Plaza, Silver Spring, MD 20910

Contact

Additional Information

FDA is hosting a public meeting on Patient-Focused Drug Development for Stimulant Use Disorder. This meeting will provide FDA the opportunity to obtain input from individuals who are struggling or have struggled with the use of cocaine, crystal meth, or misuse of prescription stimulants such as Adderall or Ritalin. Family members, advocates, caregivers and other stakeholders are encouraged to participate and share their views on the condition. In particular, FDA is interested in hearing perspectives on the:

  • Health effects and daily impacts of their condition
  • Impact (if any) of opioid and polysubstance use on their condition
  • Treatment goals
  • Decision factors considered when seeking out or selecting a treatment

This website will be updated as meeting materials are developed.  You may attend in-person or virtually. This event is FREE.

Webcast Link: http://fda.yorkcast.com/webcast/Play/89f7acb8d56e4de8827d1ade8efa42661d

Add to Calendar 03/10/2020 12:30 PM 03/10/2020 05:00 PM 15 Public Meeting on Patient-Focused Drug Development for Stimulant Use Disorder FDA is hosting a public meeting on Patient-Focused Drug Development for Stimulant Use Disorder. This meeting will provide FDA the opportunity to obtain input from individuals who are struggling or have struggled with the use of cocaine, crystal meth, or misuse of prescription stimulants such as Adderall or Ritalin. Family members, advocates, caregivers and other stakeholders are encouraged to participate and share their views on the condition. In particular, FDA is interested in hearing perspectives on the: Health effects and daily impacts of their condition Impact (if any) of opioid and polysubstance use on their condition Treatment goals Decision factors considered when seeking out or selecting a treatment This website will be updated as meeting materials are developed.  You may attend in-person or virtually. This event is FREE. Webcast Link: http://fda.yorkcast.com/webcast/Play/89f7acb8d56e4de8827d1ade8efa42661d Silver Spring Civic Building, 1 Veterans Plaza, Silver Spring, MD 20910 false MM/DD/YYYY HH:MM:SS

Get this Publication

    Contact Press Office

    301-443-6245
    media@nida.nih.gov